Recently, the website of China’s board of directors and China data research center jointly released the “2021 7th top 100 pharmaceutical enterprises in China” Guangxi Wuzhou Zhongheng Group Co.Ltd(600252) ranking 88th on the list.
It is understood that the top 1 Zoje Resources Investment Co.Ltd(002021) China Meheco Group Co.Ltd(600056) enterprises list is based on pharmaceutical enterprises listed on Shanghai and Shenzhen main board, small and medium-sized board, gem, Beijing stock exchange and new third board. Starting from the ecological construction of “healthy China”, predict and analyze the industrial trend, conduct multi-dimensional and three-dimensional assessment of marketing management indicators, financial indicators and innovation indicators, and then score and weighted summary by the experts of the jury. After layer by layer screening, the list of 100 pharmaceutical enterprises is finally determined.
Guangxi Wuzhou Zhongheng Group Co.Ltd(600252) was listed on the Shanghai Stock Exchange on November 30, 2000. It is a national high-tech enterprise, a national intellectual property demonstration enterprise and a national enterprise technology center enterprise, ranking among the top 100 China Meheco Group Co.Ltd(600056) industries, the top 100 Chinese medicine, the 19th Chinese traditional medicine enterprise and the 23rd Chinese patent medicine enterprise Guangxi Wuzhou Zhongheng Group Co.Ltd(600252) owns 11 important subsidiaries. Among them, there are 3 national high-tech enterprises and 1 listed company (Chongqing Chongqing Lummy Pharmaceutical Co.Ltd(300006) , Chongqing Lummy Pharmaceutical Co.Ltd(300006) ). The business covers pharmaceutical manufacturing, pharmaceutical research and development, health food and FMCG, medical devices, pharmaceutical circulation, traditional Chinese medicine industry and other fields.
This shortlist is the objective evaluation and full affirmation of Guangxi Wuzhou Zhongheng Group Co.Ltd(600252) years of hard work by professional institutions. After years of development, Guangxi Wuzhou Zhongheng Group Co.Ltd(600252) has achieved phased results in enterprise operation, industrial M & a development, scientific research and innovation, product development, healthy poverty alleviation and so on.
Guangxi Wuzhou Zhongheng Group Co.Ltd(600252) will continue to adhere to the idea of “stabilizing the basic market, cultivating growth points, focusing on high quality and ensuring sustainability”, build a management system oriented by benchmarking, reform the marketing system oriented by market demand, reshape the R & D system with innovation and efficiency as the goal, strengthen the investment system led by capital appreciation, and consolidate the production system focusing on cost leadership, Strive to become the “leader of healthy deep cultivation mode and practitioner of innovative exploration mode” in the field of China Meheco Group Co.Ltd(600056) health product manufacturing.
